Cencora Cost of Goods Sold 2010-2024 | COR
Cencora annual/quarterly cost of goods sold history and growth rate from 2010 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
- Cencora cost of goods sold for the quarter ending March 31, 2024 was $65.876B, a 7.71% increase year-over-year.
- Cencora cost of goods sold for the twelve months ending March 31, 2024 was $267.012B, a 11.67% increase year-over-year.
- Cencora annual cost of goods sold for 2023 was $253.214B, a 9.95% increase from 2022.
- Cencora annual cost of goods sold for 2022 was $230.291B, a 11.23% increase from 2021.
- Cencora annual cost of goods sold for 2021 was $207.046B, a 12.1% increase from 2020.
| Cencora Annual Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2023 | $253,214 |
| 2022 | $230,291 |
| 2021 | $207,046 |
| 2020 | $184,702 |
| 2019 | $174,451 |
| 2018 | $163,327 |
| 2017 | $148,598 |
| 2016 | $142,577 |
| 2015 | $132,433 |
| 2014 | $116,587 |
| 2013 | $85,451 |
| 2012 | $75,446 |
| 2011 | $76,237 |
| 2010 | $75,451 |
| 2009 | $69,660 |
| Cencora Quarterly Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2024-03-31 | $65,876 |
| 2023-12-31 | $69,784 |
| 2023-09-30 | $66,669 |
| 2023-06-30 | $64,682 |
| 2023-03-31 | $61,162 |
| 2022-12-31 | $60,701 |
| 2022-09-30 | $59,189 |
| 2022-06-30 | $58,049 |
| 2022-03-31 | $55,484 |
| 2021-12-31 | $57,568 |
| 2021-09-30 | $56,843 |
| 2021-06-30 | $51,517 |
| 2021-03-31 | $47,621 |
| 2020-12-31 | $51,064 |
| 2020-09-30 | $47,898 |
| 2020-06-30 | $44,141 |
| 2020-03-31 | $46,030 |
| 2019-12-31 | $46,634 |
| 2019-09-30 | $44,453 |
| 2019-06-30 | $44,008 |
| 2019-03-31 | $41,895 |
| 2018-12-31 | $44,095 |
| 2018-09-30 | $42,264 |
| 2018-06-30 | $41,931 |
| 2018-03-31 | $39,778 |
| 2017-12-31 | $39,354 |
| 2017-09-30 | $37,948 |
| 2017-06-30 | $37,627 |
| 2017-03-31 | $35,891 |
| 2016-12-31 | $37,132 |
| 2016-09-30 | $36,436 |
| 2016-06-30 | $35,774 |
| 2016-03-31 | $34,623 |
| 2015-12-31 | $35,744 |
| 2015-09-30 | $34,497 |
| 2015-06-30 | $33,342 |
| 2015-03-31 | $31,757 |
| 2014-12-31 | $32,836 |
| 2014-09-30 | $30,716 |
| 2014-06-30 | $29,656 |
| 2014-03-31 | $27,726 |
| 2013-12-31 | $28,488 |
| 2013-09-30 | $23,901 |
| 2013-06-30 | $21,344 |
| 2013-03-31 | $19,807 |
| 2012-12-31 | $20,399 |
| 2012-09-30 | $18,031 |
| 2012-06-30 | $18,659 |
| 2012-03-31 | $19,029 |
| 2011-12-31 | $19,728 |
| 2011-09-30 | $18,348 |
| 2011-06-30 | $19,507 |
| 2011-03-31 | $19,073 |
| 2010-12-31 | $19,308 |
| 2010-09-30 | $18,977 |
| 2010-06-30 | $19,014 |
| 2010-03-31 | $18,689 |
| 2009-12-31 | $18,772 |
| 2009-09-30 | $18,178 |
| 2009-06-30 | $17,875 |
| 2009-03-31 | $16,759 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $44.832B | $262.173B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $122.161B | 15.33 |
| DiDi Global (DIDIY) | China | $24.983B | 0.00 |
| ICON (ICLR) | Ireland | $24.837B | 23.45 |
| Avantor (AVTR) | United States | $16.520B | 24.32 |
| Viatris (VTRS) | United States | $13.812B | 3.97 |
| CochLear (CHEOY) | Australia | $13.622B | 0.00 |
| Revvity (RVTY) | United States | $12.486B | 21.88 |
| Medpace Holdings (MEDP) | United States | $12.117B | 39.86 |
| Charles River Laboratories (CRL) | United States | $11.842B | 21.59 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.592B | 0.00 |
| Natera (NTRA) | United States | $11.317B | 0.00 |
| Solventum (SOLV) | United States | $11.238B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.201B | 0.00 |
| HealthEquity (HQY) | United States | $6.843B | 51.12 |
| Organon (OGN) | United States | $5.015B | 4.76 |
| Bausch + Lomb (BLCO) | Canada | $4.870B | 19.52 |
| Doximity (DOCS) | United States | $4.537B | 33.78 |
| PACS (PACS) | United States | $3.752B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.178B | 29.41 |
| Sotera Health (SHC) | United States | $3.088B | 15.15 |
| Progyny (PGNY) | United States | $3.082B | 51.73 |
| Life Times (LTH) | United States | $2.779B | 29.44 |
| GoodRx Holdings (GDRX) | United States | $2.769B | 140.20 |
| Premier (PINC) | United States | $2.543B | 9.31 |
| AMN Healthcare Services Inc (AMN) | United States | $2.281B | 7.38 |
| Teladoc Health (TDOC) | United States | $2.203B | 0.00 |
| Agilon Health (AGL) | United States | $1.985B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.893B | 0.00 |
| NovoCure (NVCR) | Jersey | $1.527B | 0.00 |
| Agiliti (AGTI) | United States | $1.369B | 22.36 |
| Establishment Labs Holdings (ESTA) | $1.359B | 0.00 | |
| Alignment Healthcare (ALHC) | United States | $1.003B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.766B | 7.93 |
| Embecta (EMBC) | United States | $0.589B | 3.89 |
| InnovAge Holding (INNV) | United States | $0.554B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.511B | 0.00 |
| LifeMD (LFMD) | United States | $0.511B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.508B | 0.00 |
| Enhabit (EHAB) | United States | $0.501B | 45.41 |
| Auna S.A (AUNA) | Luxembourg | $0.500B | 0.00 |
| CareDx (CDNA) | United States | $0.480B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.466B | 0.00 |
| MultiPlan (MPLN) | United States | $0.429B | 0.00 |
| Beauty Health (SKIN) | United States | $0.399B | 0.00 |
| DocGo (DCGO) | United States | $0.366B | 58.50 |
| Sera Prognostics (SERA) | United States | $0.345B | 0.00 |
| ModivCare (MODV) | United States | $0.312B | 5.85 |
| Sharecare (SHCR) | United States | $0.269B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.265B | 0.00 |
| Biodesix (BDSX) | United States | $0.150B | 0.00 |
| So-Young (SY) | China | $0.128B | 43.00 |
| Oncology Institute (TOI) | United States | $0.086B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.072B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
| NeueHealth (NEUE) | United States | $0.050B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.038B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.037B | 0.00 |
| Nutex Health (NUTX) | United States | $0.032B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
| OncoCyte (OCX) | United States | $0.023B | 0.00 |
| DermTech (DMTK) | United States | $0.022B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.014B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| Assure Holdings (IONM) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |